$91.21▾ 0.71%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$1.18cash per $1 profit
Strong
It turns every reported profit-dollar into real cash, and then some.
Valuation
69th pctvs its own history
Fair
Its valuation is around the middle of its own recent range.
Revenue growth
+0.3%year over year
Watch
Revenue growth has flattened.
Leverage
Not enough data yet
Term-debt data is not available for this company.
More coming: dilution / share-count creep.
Fair value
Overvalued
Trading about 8% above our fair-value range
A cash-flow (DCF) estimate cross-checked against peer multiples.
✦ The read
iRadimed Corporation turns 118¢ of every reported profit-dollar into real cash. Revenue growth has flattened. Its valuation is around the middle of its own recent range.
Key numbers
Valuation
EPS (TTM)$1.79
TTM (trailing 12 months, through fiscal Q2 FY2026)
Profitability
Net margin26.7%
TTM (trailing 12 months, through fiscal Q2 FY2026)
Size
Revenue (TTM)$86.34M
TTM (trailing 12 months, through fiscal Q2 FY2026)
Signals and key numbers are from the fiscal Q2 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.